News

Site is located in the state of Gujarat, a major hub for pharma logistics

Collaboration focuses on continuing to improve time to therapy and medication adherence for patients, while effectively optimizing clinical data

Upon deal completion, group will acquire company’s oncology product portfolio for $846 million

CDMO’s financial commitment will feature construction of a new GMP clinical trial development facility

Latest report indicates that air cargo demand is outperforming pre-Covid stats from 2019

Financial commitment is predicted to more than double the biopharma site’s manufacturing capabilities

Transaction expands CDMO’s services, including more solutions surrounding commercial manufacturing

Five-year deal covers manufacturing of molecules, ranging from monoclonal antibodies to antibody-drug conjugates

Subject to regulatory approval, CDMO will produce mRNA vaccine on a commercial scale

The biggest areas of adjustment in patient support brought on by changes in consumer and physician behavior

The Discovery Centre will be powered by AI technology, robotics, among other features

Transaction is anticipated to further Novo’s research in the field of RNAi therapeutics

Acquisition of biopharma company features sotatercept, which is in Phase III trials for the treatment of pulmonary arterial hypertension

Financial commitment expected to increase plant's process development and manufacturing capacity

Approval is for the 50-µg dosage

Opens a ‘Cold Chain Packaging Center of Excellence’ in Kentucky, while expanding services globally

ConvergeHEALTH Safety intended to automate pharmacovigilance case processing

Separation process expected to be completed in 18-24 months

White House announces official endorsement, paving way for Senate confirmation process

It’s not just innovator pharma companies concerned with the proposed compromise to Medicare price negotiations and inflation-based rebates

Expansion expected to more than double the plant’s footprint

PBM fees and vertical integration are also at the top of the list

CDMO’s expansion of Hopkinton, MA facility will include seven new ISO 7 cGMP suites

Deal expected to boost firm’s offerings via FDS's delivery system services

Partnership further increases investment firm’s repertoire in healthcare space

Boston area facility will focus heavily on cold chain services

Parties expect improved design and selection of eCOAs in decentralized clinical trials

Latest report shows that demand is above pre-crisis numbers, but there are still capacity constraints